Show item record

dc.contributor.advisorKarakiewicz, Pierre
dc.contributor.authorJeldres, Claudio
dc.date.accessioned2014-05-28T15:47:22Z
dc.date.availableNO_RESTRICTIONfr
dc.date.available2014-05-28T15:47:22Z
dc.date.issued2014-05-20
dc.date.submitted2012-03
dc.identifier.urihttp://hdl.handle.net/1866/10589
dc.subjectProstatefr
dc.subjectCancerfr
dc.subjectÉpidémiologiefr
dc.subjectEpidemiologyfr
dc.subject.otherHealth Sciences - Epidemiology / Sciences de la santé - Épidémiologie (UMI : 0766)fr
dc.titleA systematic analysis of the detrimental effect of hormonotherapy on skeletal and non-skeletal morbidities in male with prostate cancerfr
dc.typeThèse ou mémoire / Thesis or Dissertation
etd.degree.disciplineSciences biomédicalesfr
etd.degree.grantorUniversité de Montréalfr
etd.degree.levelMaîtrise / Master'sfr
etd.degree.nameM. Sc.fr
dcterms.abstractPlusieurs patients atteints d’un cancer de la prostate (CaP) se verront prescrire l'hormonothérapie (HT) en raison du stade avancé ou en cas d’une récidive de la maladie, pour freiner la progression de la maladie et améliorer leur survie. Cependant, l’HT présente des effets pouvant nuire significativement à la santé du patient.fr
dcterms.abstractMany prostate cancer patients will be treated with hormonotherapy (HT), depending of the cancer stage. But HT presents some side effects that could be harmful to the patient.fr
dcterms.languageengfr


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show item record

This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.